AR226806A1 - Procedimiento para la preparacion de 3,20-dioxo-7 alfa-halo-4-pregnenos y-1,4-pregnadienos - Google Patents
Procedimiento para la preparacion de 3,20-dioxo-7 alfa-halo-4-pregnenos y-1,4-pregnadienosInfo
- Publication number
- AR226806A1 AR226806A1 AR270418A AR27041877A AR226806A1 AR 226806 A1 AR226806 A1 AR 226806A1 AR 270418 A AR270418 A AR 270418A AR 27041877 A AR27041877 A AR 27041877A AR 226806 A1 AR226806 A1 AR 226806A1
- Authority
- AR
- Argentina
- Prior art keywords
- pregnadiene
- pregnene
- dioxo
- halo
- alpha
- Prior art date
Links
Classifications
-
- E—FIXED CONSTRUCTIONS
- E04—BUILDING
- E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
- E04G11/00—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs
- E04G11/06—Forms, shutterings, or falsework for making walls, floors, ceilings, or roofs for walls, e.g. curved end panels for wall shutterings; filler elements for wall shutterings; shutterings for vertical ducts
- E04G11/20—Movable forms; Movable forms for moulding cylindrical, conical or hyperbolical structures; Templates serving as forms for positioning blocks or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/001—Lactones
- C07J21/003—Lactones at position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0084—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkylene group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
-
- E—FIXED CONSTRUCTIONS
- E04—BUILDING
- E04G—SCAFFOLDING; FORMS; SHUTTERING; BUILDING IMPLEMENTS OR AIDS, OR THEIR USE; HANDLING BUILDING MATERIALS ON THE SITE; REPAIRING, BREAKING-UP OR OTHER WORK ON EXISTING BUILDINGS
- E04G17/00—Connecting or other auxiliary members for forms, falsework structures, or shutterings
- E04G17/14—Bracing or strutting arrangements for formwalls; Devices for aligning forms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Architecture (AREA)
- Engineering & Computer Science (AREA)
- Civil Engineering (AREA)
- Mechanical Engineering (AREA)
- Structural Engineering (AREA)
- Animal Behavior & Ethology (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Medicinal Chemistry (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75325676A | 1976-12-22 | 1976-12-22 | |
US05/753,257 US4076708A (en) | 1976-12-22 | 1976-12-22 | Process for the preparation of 7α-halogeno-3-oxo-4-dehydro steroids and novel 7α-halogeno derivatives produced thereby |
Publications (1)
Publication Number | Publication Date |
---|---|
AR226806A1 true AR226806A1 (es) | 1982-08-31 |
Family
ID=27115720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AR270418A AR226806A1 (es) | 1976-12-22 | 1977-12-19 | Procedimiento para la preparacion de 3,20-dioxo-7 alfa-halo-4-pregnenos y-1,4-pregnadienos |
Country Status (20)
Country | Link |
---|---|
JP (1) | JPS604198B2 (fi) |
AR (1) | AR226806A1 (fi) |
AT (2) | AT373269B (fi) |
BE (1) | BE862089A (fi) |
DE (1) | DE2756550C2 (fi) |
DK (1) | DK153494C (fi) |
FI (1) | FI63947C (fi) |
FR (1) | FR2384793A1 (fi) |
GB (1) | GB1575983A (fi) |
HK (1) | HK584A (fi) |
HU (1) | HU179784B (fi) |
IE (1) | IE45950B1 (fi) |
IL (1) | IL53636A (fi) |
MY (1) | MY8500082A (fi) |
NL (1) | NL180479C (fi) |
NO (1) | NO151826C (fi) |
NZ (1) | NZ186031A (fi) |
PT (1) | PT67432B (fi) |
SE (1) | SE429865B (fi) |
SG (1) | SG58683G (fi) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109680036A (zh) | 2017-10-02 | 2019-04-26 | 爱科来株式会社 | 糖化蛋白质的测定 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3429926A (en) * | 1964-05-25 | 1969-02-25 | Squibb & Sons Inc | 7-halo and 6-halo,6-dehydro a-norprogesterones |
-
1977
- 1977-12-13 GB GB51805/77A patent/GB1575983A/en not_active Expired
- 1977-12-19 AT AT0909477A patent/AT373269B/de not_active IP Right Cessation
- 1977-12-19 JP JP52152835A patent/JPS604198B2/ja not_active Expired
- 1977-12-19 NZ NZ186031A patent/NZ186031A/en unknown
- 1977-12-19 DE DE2756550A patent/DE2756550C2/de not_active Expired
- 1977-12-19 FR FR7738297A patent/FR2384793A1/fr active Granted
- 1977-12-19 IL IL53636A patent/IL53636A/xx unknown
- 1977-12-19 IE IE2576/77A patent/IE45950B1/en not_active IP Right Cessation
- 1977-12-19 AR AR270418A patent/AR226806A1/es active
- 1977-12-19 PT PT67432A patent/PT67432B/pt unknown
- 1977-12-19 NL NLAANVRAGE7714056,A patent/NL180479C/xx not_active IP Right Cessation
- 1977-12-19 NO NO774359A patent/NO151826C/no unknown
- 1977-12-19 FI FI773825A patent/FI63947C/fi not_active IP Right Cessation
- 1977-12-20 SE SE7714538A patent/SE429865B/sv not_active IP Right Cessation
- 1977-12-20 BE BE183654A patent/BE862089A/xx not_active IP Right Cessation
- 1977-12-20 DK DK569977A patent/DK153494C/da not_active IP Right Cessation
- 1977-12-21 HU HU77SCHE635A patent/HU179784B/hu unknown
-
1980
- 1980-11-25 AT AT0575980A patent/AT377566B/de not_active IP Right Cessation
-
1983
- 1983-09-09 SG SG586/83A patent/SG58683G/en unknown
-
1984
- 1984-01-05 HK HK5/84A patent/HK584A/xx not_active IP Right Cessation
-
1985
- 1985-12-30 MY MY82/85A patent/MY8500082A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR215000A1 (es) | Procedimiento para la preparacion de c-076 | |
AR222007A1 (es) | Procedimiento para la preparacion de nuevos hentriacontapeptidos | |
MX6046E (es) | Procedimiento para la preparacion de 4,5-diaril-2-nitro-imidazoles | |
ES496442A0 (es) | Un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina | |
MX4089E (es) | Procedimiento mejorado para la preparacion de n-fosfonometilglicina | |
AR224095A1 (es) | Procedimiento de preparacion de nuevos derivados de ditiol-1,2 tiona-3 | |
AR220683A1 (es) | Procedimiento para la preparacion de m-fenoxibenzaldehido | |
AR220684A1 (es) | Metodo para la preparacion de 1-fenil-3-azabiciclo(3.1.0)hexanos | |
AR215875A1 (es) | Procedimiento para la prepararacion de meta-fenoxi-benzaldehido | |
MX6242E (es) | Procedimiento para la preparacion de 1,2,3,5,tetrahidroimidazotienopirimidin-2-onas | |
AR211887A1 (es) | Procedimiento para la preparacion de derivados de endolizina | |
MX4972E (es) | Procedimiento mejorado para la preparacion de 7 beta-oxiimmino-acilcefalosporinas | |
MX4664E (es) | Procedimiento mejorado para la preparacion de derivados de n-fosfonometilglicina | |
MX4820E (es) | Procedimiento para la preparacion de derivados de 5,6-cia y-5,6-trans-10,19-dihidro vitamina d | |
ES456483A0 (es) | Procedimiento para la preparacion de compuestos de estilbeno. | |
MX4796E (es) | Procedimiento para la preparacion de derivados de 2-iminotiazolina | |
AR213430A1 (es) | Procedimiento para la preparacion de nuevas n-cianoalquil-p-halofenoxi-isobutiramidas | |
ES491683A0 (es) | Procedimiento para la preparacion de 1,3,7-trialquilxantinas | |
RO75589A (ro) | Procedeu pentru prepararea 2,6-metan-2h-1-benzoxocinei | |
MX5685E (es) | Procedimiento para la preparacion de 4,5-diaril-2-(tio-substituido)-pirrol | |
AR217664A1 (es) | Procedimiento para la preparacion de derivados de oleandomicina | |
MX4750E (es) | Procedimiento para la preparacion de gamma-pironas | |
AR230642A1 (es) | Procedimiento para la preparacion de un indoledihidroindolcarboxamida dimerica | |
MX147640A (es) | Procedimiento para la preparacion de compuestos de 4 6-5-beta-sulfatoetilsulfonil-2-amino-fenol | |
MX4770E (es) | Procedimiento mejorado para la preparacion de trans-3,3,5-trimetilciclohexil etileter |